These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34649856)

  • 1. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients.
    Kanabar G; Wilkinson P
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34649856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome.
    Meo SA; Shaikh N; Abukhalaf FA; Meo AS
    Sci Rep; 2024 Aug; 14(1):18767. PubMed ID: 39138276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
    Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
    Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
    Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
    Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
    Oo WM; Giri P; de Souza A
    J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The First Guillain-Barr? Syndrome After SARS-CoV-2 Vaccination in Taiwan.
    Su SC; Lyu RK; Chang CW; Tseng WJ
    Acta Neurol Taiwan; 2022 Jan; 31(1)():46-51. PubMed ID: 34988954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral facial palsy after COVID-19 vaccination.
    Andreozzi V; D'arco B; Pagliano P; Toriello A; Barone P
    Neurol Sci; 2022 Jul; 43(7):4069-4079. PubMed ID: 35364768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillan-Barré Syndrome after First Vaccination Dose against COVID-19: Case Report.
    Čenščák D; Ungermann L; Štětkářová I; Ehler E
    Acta Medica (Hradec Kralove); 2021; 64(3):183-186. PubMed ID: 34779385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
    Rossetti A; Gheihman G; O'Hare M; Kosowsky JM
    J Emerg Med; 2021 Dec; 61(6):e141-e145. PubMed ID: 34538679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
    Bouattour N; Hdiji O; Sakka S; Fakhfakh E; Moalla K; Daoud S; Farhat N; Damak M; Mhiri C
    Neurol Sci; 2022 Feb; 43(2):755-761. PubMed ID: 34796417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN.
    Tutar NK; Eyigürbüz T; Yildirim Z; Kale N
    Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
    Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
    Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
    Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome after COVID-19 vaccination.
    McKean N; Chircop C
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of Guillain-Barré syndrome following COVID-19 vaccine.
    Hasan T; Khan M; Khan F; Hamza G
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34187803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
    Germano F; Bellucci M; Grisanti S; Beronio A; Grazzini M; Coco E; Tassinari T; Della Cava F; De Michelis C; Baldi O; Sivori G; Murialdo A; Cabona C; Durando P; Uccelli A; Schenone A; Franciotta D; Benedetti L
    J Neurol Sci; 2022 Sep; 440():120330. PubMed ID: 35802961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromyoneurography and laboratory findings in a case of Guillain-Barré syndrome after second dose of Pfizer COVID-19 vaccine.
    Scendoni R; Petrelli C; Scaloni G; Logullo FO
    Hum Vaccin Immunother; 2021 Nov; 17(11):4093-4096. PubMed ID: 34347563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review.
    Liang H; Cao Y; Zhong W; Ma Z; Liu J; Chen H
    Hum Vaccin Immunother; 2022 Nov; 18(6):2125753. PubMed ID: 36315834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post coronavirus disease-2019 vaccination Guillain-Barré syndrome.
    Biswas A; Pandey SK; Kumar D; Vardhan H
    Indian J Public Health; 2021; 65(4):422-424. PubMed ID: 34975092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.